Life Science Developments Limited (CDC) : Company Profile and SWOT Analysis
Timetric's "Life Science Developments Limited (CDC) : Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, recent developments, key employees, company locations and subsidiaries as well as employee biographies.
This report is a crucial resource for industry executives and anyone looking to access key information about "Life Science Developments Limited"
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Examines and identifies key information and issues about "Life Science Developments Limited" for business intelligence requirements.
Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
The profile also contains information on business operations, company history, major products and services, key employees, and locations and subsidiaries.
Reasons To Buy
Quickly enhance your understanding of "Life Science Developments Limited"
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
Increase business/sales activities by understanding your competitors’ businesses better.
Recognize potential partnerships and suppliers.
Life Science Developments Limited (LSDL), formally known as Copper Development Corporation, is a development stage mining company in the UK. The company involves in the exploration, development, mining and processing of minerals, petroleum and mineral oils. In FY2015, the company has completed the sale of the Basay and Hinoba-an project in Philippines. In addition, it also disposed the subsidiary CDC Philippines Holdings Limited. The company plans to invest in within the biotechnology, life sciences and in the other technologies. The company focuses on North America, Asia and Europe. LSDL is headquartered in Douglas, the UK.